Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and WalesArticle Published on 2022-10-152022-11-16 Journal: Lancet (London, England) [Category] COVID19(2023년), SARS, 변종, [키워드] 95% CI adjusted age analyses analysis Analysis aRR association B.1.1.529 benefit BNT162b2 booster booster dose Booster vaccine calculated ChAdOx1 nCoV-19 Chronic kidney disease Committee Comorbidities Comorbidity conducted core covariates COVID-19 COVID-19 hospitalisation COVID-19 infection COVID-19 therapeutics COVID-19 vaccination current death dominant Edinburgh England event group Health health condition high risk hospitalisation identify immunisation Immunosuppressant increased risk individual initial Innovation Ireland male Medical Research Council meta-analyses Moderna mortality data mRNA-1273 Multimorbidity National of BNT162b2 offer older adult outcome outcomes Oxford-AstraZeneca per 1000 person-year per 1000 person-years Pfizer-BioNTech Poisson regression model primary care prospective cohort prospective cohort study rate ratio receiving reduced reduced risk remained risk risk factor RT-PCR testing SARS-COV-2 infection Scottish severe COVID-19 Sex those with comorbidity university vaccination Vaccine vaccine dose vaccine group variant [DOI] 10.1016/S0140-6736(22)01656-7 PMC 바로가기
An international observational study to assess the impact of the Omicron variant emergence on the clinical epidemiology of COVID-19 in hospitalised patientsArticle Published on 2022-10-052022-11-16 Journal: eLife [Category] COVID19(2023년), SARS, 변종, [키워드] adjusted analysis Analysis Appendix approach assumption available data Calabria carrier caused changes in characterisation clinical Clinical outcome Clinical research clinical study collected Commonwealth confidence interval confounders COVID-19 dataset DAVID development Donor emergence Epidemiology European European Commission fatality Foreign foundation Frequency funding global health Google.org group heterogeneity Horizon hospital hospitalised hospitalised patient Imperial College London include infecting Infection Infectious disease International IRCCS ISARIC Italian Joshua less Logistic regression lower mortality Medical Research Council Medicine Melinda Gate Microbiology Ministry of Health network NIHR NIHR HPRU Odds ratio office omicron opportunity outcome Oxford Patient PHE protection Public Health England Rapid relative frequencies reported symptom Research respiratory response responsible Rockefeller Foundation SARS-CoV-2 variant School Semple sensitivity analysis Sriniva study population subset Support supported Symptoms union unit University of Liverpool University of Oxford variant variants viral genomic information viruses viruses. with COVID-19 [DOI] 10.7554/eLife.80556 PMC 바로가기
SARS-CoV-2 antibody dynamics in blood donors and COVID-19 epidemiology in eight Brazilian state capitals: A serial cross-sectional studyArticle Published on 2022-09-222022-11-15 Journal: eLife [Category] SARS, 변종, 진단, [키워드] age antibody waning attack rate Blood blood donor Blood donors Brazil circulating complex country COVID-19 COVID-19 situation CrI cross-sectional disease dominant Donor eight Epidemic Epidemics Epidemiology fatality Fatality rate Fazer foundation Gamma Gate global health health system heterogeneity highlight hospitalisation IFR IgG antibody Infection Infection fatality rate JBS Medical Research Council morbidity Older outbreak ranged respiratory pathogen SARS-CoV-2 SARS-CoV-2 antibody second wave sensitivity Seroprevalence Serosurveillance significantly Society specificity Spread supported tested understanding utility variant viruses viruses. VoC Weekly Wellcome Trust were used women [DOI] 10.7554/eLife.78233 PMC 바로가기
Effectiveness of rapid SARS-CoV-2 genome sequencing in supporting infection control for hospital-onset COVID-19 infection: Multicentre, prospective studyArticle Published on 2022-09-132022-11-15 Journal: eLife [Category] SARS, 진단, 치료기술, [키워드] 95% CI Admission baseline Capacity changed clinical COG-UK collected conducted COVID-19 COVID-19 infection detect Epidemiology evaluated Evidence extreme global health HAI Health Service Healthcare-associated infection hospital Hospital-acquired infection Human incidence incidence rate Infection infection control Infection prevention Infectious disease Innovation Intervention knowledge Limited Medical Research Council Microbiology molecular Molecular epidemiology MRC NIHR non-randomised trial nosocomial outbreak per-protocol Prospective Study resources respond returned SARS-CoV-2 SARS-CoV-2 genome sequencing sensitivity analysis sequence Sequencing Site statistically significant supported Transmission Trial viral genomics. Volume Wellcome Sanger Institute were recorded while [DOI] 10.7554/eLife.78427 PMC 바로가기
Decline in antibody responses to SARS-CoV-2 post-vaccination poses a risk to health care workers예방 접종 후 SARS-CoV-2에 대한 항체 반응 감소는 의료 종사자에게 위험을 초래합니다Article Published on 2022-09-012022-09-11 Journal: The Journal of Infection [Category] COVID19(2023년), SARS, 변종, [키워드] Abbreviations: HCW, health care worker Abstract African Antibody Response Care Decline HCW Health Health care Health care worker IGG, immunoglobulin g IGM, immunoglobulin m Immunoglobulin Immunoglobulin G immunoglobulin M interquartile interquartile range IQR IQR, interquartile range lateral flow lateral flow immunoassay LFIA LFIA, lateral flow immunoassay Medical Research Council POC POC, point-of-care product risk SA-MRC, South African Medical Research Council SAHPRA, South African Health Products Authority SARS-CoV-2 South variant VoC VOC, variant of concern. [DOI] 10.1016/j.jinf.2022.06.008 PMC 바로가기 [Article Type] Article
A First View of the Effect of a Trial of Early Mobilization on the Muscle Strength and Activities of Daily Living in Mechanically Ventilated Patients With COVID-19Research article Published on 2022-09-012022-10-05 Journal: Archives of Rehabilitation Research and Clinical Translation [Category] 임상, [키워드] Activities of Daily Living activity Barthel Index Care COVID-19 Daily daily living Early Ambulation Effect functional groups Inpatient intensive care Intervention Japan male manual measure mechanical ventilation Medical Research Council Mobility mobilization muscle Muscle strength no difference objective outcome measure participant Patient patients with COVID-19 postintervention rehabilitation Respiration Result retrospective scale setting severe COVID-19 significantly single-center small sample size statistically significant strength subject Test View [DOI] 10.1016/j.arrct.2022.100201 [Article Type] Research article
Vaccine effectiveness of two-dose BNT162b2 against symptomatic and severe COVID-19 among adolescents in Brazil and Scotland over time: a test-negative case-control studyResearch article Published on 2022-08-092022-10-05 Journal: The Lancet. Infectious Diseases [Category] SARS, 변종, [키워드] 95% CI Abstract adjusted odds ratio analysed Antigen association B.1.1.529 BNT162b2 booster dose Brazil case-control study collected Control Council country COVID-19 COVID-19 infection COVID-19-related symptom death dose Effectiveness excluded Fazer finding funding hospitalisation individual information Innovation material Medical Research Council National negative test Occurrence of BNT162b2 outcome peaked Positive test receiving recorded reducing remained SARS-CoV-2 SARS-CoV-2 RT-PCR SARS-CoV-2 test Scottish second dose severe COVID-19 severe disease Sex significantly lower symptom onset symptomatic symptomatic infection symptomatic SARS-CoV-2 infection Symptoms the SARS-CoV-2 translation vaccination Vaccine vaccine efficacy variant Wellcome Trust [DOI] 10.1016/S1473-3099(22)00451-0 [Article Type] Research article
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysisCOVID-19로 병원에 입원한 환자의 바리시티닙(RECOVERY): 무작위, 통제, 공개 라벨, 플랫폼 시험 및 업데이트된 메타 분석Meta-Analysis Published on 2022-07-302022-09-11 Journal: Lancet (London, England) [Category] COVID19(2023년), SARS, 임상, [키워드] 1:1 28-day mortality 95% CI age-adjusted rate ratio allocation Baricitinib benefit by mouth cause Corticosteroid Corticosteroids COVID-19 COVID-19 therapy death deaths died discharge eight enrolled evaluate Evidence hospital hospitalised Including Infection inhibitor Innovation intention-to-treat population ISRCTN Jak JAK inhibitor jak inhibitors janus Janus kinase Medical Research Council Meta-analysis mouth nine Non-COVID-19 once daily Open-label outcomes Patient Platform trial Primary outcome Proportional reduction randomisation randomised randomised controlled trial Randomised Evaluation Randomly randomly assigned patient rate ratio receive receiving recorded recovery RECOVERY trial reduce mortality reduced reduction in mortality Registered risk of death significantly Standard of care suggested thrombosis Tocilizumab Treatment Trial trials usual care usual care alone usual care group was done with COVID-19 [DOI] 10.1016/S0140-6736(22)01109-6 PMC 바로가기 [Article Type] Meta-Analysis
COVID-19 and Guillain-Barré syndrome: A single-center prospective case series with a 1-year follow-upCOVID-19 및 Guillain-Barré 증후군: 1년 추적 관찰이 포함된 단일 센터 전향적 사례 시리즈Observational Study Published on 2022-07-292022-09-11 Journal: Medicine [Category] COVID19(2023년), SARS, 변종, 임상, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Admission antecedent antibody association bystander Case report case reports case sery cerebrospinal fluid clinical clinical feature Clinical presentations Clustering Computerized tomography consecutive patient coronavirus COVID-19 diagnosed disability feature Follow-up Guillain-barrè syndrome highlight hospital incidence Infection involved Italian Laboratory lack lymphopenia Medical Research Council Nasopharyngeal swab neurological Neurological diseases no difference no differences observational study pandemic patients patients with SARS-CoV-2 Pneumonia positive Prevalence Prognosis reduction Referral Region reported response to treatment retrospective SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 RNA severe acute respiratory syndrome Coronavirus severity single-center Spectrum subtype Support Swab syndrome systemic inflammation Temporal Treatment university Waves while X-ray [DOI] 10.1097/MD.0000000000029704 PMC 바로가기 [Article Type] Observational Study
Long-term functioning status of COVID-19 survivors: a prospective observational evaluation of a cohort of patients surviving hospitalisationObservational Study Published on 2022-07-272022-10-04 Journal: BMJ Open [Category] COVID19(2023년), SARS, 임상, [키워드] 24 hour activities acute SARS-CoV-2 infection age analogue analysis Anxiety assessment Borg Brazil breathlessness Care chronic clinical manifestations cohort of patient COVID-19 daytime Depression disability fatigue functional Functional status handgrip strength hospital hospital discharge hospitalisation hospitalised illness Independence indicated Insomnia Insomnia Severity Index intake Invasive mechanical ventilation investigated Long-term condition measure Medical Research Council MOST MRC muscle oral Pain participant prevalent prospective observational study public health reduced rehabilitation medicine. reported required scale schedule sleepiness Sociodemographic Stand strength survivor Survivors Test treat university hospital Visual weakness WHO [DOI] 10.1136/bmjopen-2021-057246 PMC 바로가기 [Article Type] Observational Study